NCT03139240.
Study name | Opioid analgesia for MAB |
Methods | "Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Investigator)
Masking Description:Double Blind Primary Purpose: Treatment" |
Participants | "Inclusion Criteria:
Exclusion Criteria:
|
Interventions | "Drug: Oxycodone 10mg oral Oxycodone 10mg oral given for pain control in addition to standard of care medications in women undergoing medical abortion Other: Placebo Placebo given in addition to standard of care medications in women undergoing medical abortion" |
Outcomes |
Women text responses through two surveys within 24 hours after misoprostol administration indicating their maximum self‐reported pain score on an 11‐point Numeric Pain Rating Scale (0 = no pain, 5 = moderate pain, and 10 = worst possible pain).
Women text responses through two surveys within 24 hours after misoprostol administration indicating their maximum self‐reported pain score on an 11‐point Numeric Pain Rating Scale (0 = no pain, 5 = moderate pain, and 10 = worst possible pain).
Women text responses through two surveys within 24 hours after misoprostol administration indicating their maximum self‐reported pain score on an 11‐point Numeric Pain Rating Scale (0 = no pain, 5 = moderate pain, and 10 = worst possible pain)" |
Starting date | 01 May 2017 |
Contact information | Oregon Health and Science University |
Notes |